1. Home
  2. BOLT

BOLT

Bolt Biotherapeutics Inc.

Logo Bolt Biotherapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Founded: 2015 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 48.4M IPO Year: 2021
Target Price: $6.00 AVG Volume (30 days): 130.3K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.83 EPS Growth: N/A
52 Week Low/High: $0.84 - $2.03 Next Earning Date: 05-09-2024
Revenue: $7,876,000 Revenue Growth: 37.48%
Revenue Growth (this year): 15.93% Revenue Growth (next year): -36.28%

Share on Social Networks: